CMS’ obesity drug coverage implications for nursing home patients; Independent pharmacies supplying LTC could drop lower-priced drugs in new Medicare program ...

The objective of this study was to ascertain the effect of weight loss over the course of 1 year on 5-year mortality in old nursing home (NH) residents in different classes of body mass index (BMI).

Treatment with tirzepatide led to significant weight loss in adults with obesity or overweight with weight-related comorbidities (excluding type 2 diabetes), according to results from the phase 3 ...

Significant weight loss of at least 5% occurred in 40% of residents, with 47% of those losing 10% or more of their weight. Men in the study were 14 times more likely to lose significant weight due ...

Clinically significant weight loss wasn't very common in U.S. adults with overweight or obesity, a cohort study suggested. In a sample of nearly 18.5 million ambulatory adults followed for ...

AUSTIN, Texas--(BUSINESS WIRE)--Today, Found, the leading specialized weight care telehealth platform, announced a landmark study published in Obesity Science & Practice, assessing weight loss ...

CagriSema patients lost more weight than those taking either component alone: 20.4% for the combination vs 11.5% with cagrilintide, 14.9% with semaglutide, and 3% with placebo.

What if losing weight isn’t the key to getting healthy — and might even make things worse? A growing number of doctors say ...

Secret behind maintaining a healthy weight loss Date: May 6, 2021 Source: University of Copenhagen - The Faculty of Health and Medical Sciences Summary: ...